Targeting vaccine campaigns only at vulnerable groups in future will, paradoxically, leave them at greater risk.
Academic rigor, journalistic flair
Articles on COVID vaccines UK
Displaying 1 - 20 of 21 articles
Clinically vulnerable people tended not to respond as well after the first and second shots, but their immunity rises to greater levels with a booster.
Data suggests the bivalent boosters are working well against omicron.
We don’t have a lot of scientific evidence on how much additional protection a fourth dose would offer younger adults. But on balance, giving them the option could be worthwhile.
For one, washing your hands is unlikely to prevent COVID spread.
The mental wellbeing benefits associated with COVID vaccination were substantial among older and clinically vulnerable people, but negligible for younger adults.
An immunologist looks at the evidence.
The UK has become the first country to approve the shot, which targets omicron alongside the original strain of SARS-CoV-2.
A new study looked at the health records of more than 9 million people in England to assess whether body weight influenced the uptake and effectiveness of COVID vaccines.
‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.
The proportion of children aged five to 11 in the UK who have been vaccinated against COVID remains quite low. Why?
Pfizer and Moderna have both recently reported results for their COVID-19 vaccines in the youngest children.
A study of more than 28,000 UK adults has found that vaccination after having COVID is linked to a decrease in long COVID symptoms.
Scientists are working on intranasal COVID vaccines. Not only are these vaccines delivered differently – but they also target a different part of our immune system.
Despite being an excellent vaccine, the use of AstraZeneca in the UK has declined over the course of the COVID pandemic.
Fourth doses are now being offered to vulnerable groups. But if you’re young and healthy, will you need one?
New ethical issues are emerging during COVID-19 as doctors struggle with their obligations to ‘do no harm’ and respect patient autonomy.
Removing contractual sick pay could open employers up to legal challenges.
The country appears to have created two highly protective jabs – though rigorous data on their testing still needs to be seen.
Looking solely at health benefits, the case for vaccinating primary schoolers isn’t strong.
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Viral Oncology, University of Leeds
-
Lecturer in Psychology, Swansea University
-
Personal Chair of Immunopathology, The University of Edinburgh
-
Virologist, Queen's University Belfast
-
Professor of Law, University of Liverpool
-
Lecturer in Law, University College Cork
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Senior Researcher, Diet and Obesity, University of Oxford
-
Professor of Economics and Behavioural Science, University of Leeds
-
Professor of Primary Care Health Sciences, University of Oxford
-
Senior Lecturer in Immunology, Cardiff Metropolitan University
-
Professor of Medicine, University of East Anglia
-
Research Fellow in Virology, University of Leeds
-
Associate Head (Students), School of Biological Sciences, University of Portsmouth
